Robert Boorstein News Today : Breaking News, Live Updates & Top Stories | Vimarsana

HHS is sending tests to large commercial labs while other labs are prepping assays as part of what some suggest is a more coordinated response than that to COVID-19.

Issues like staffing shortages and supply chain gaps combined with fluctuating demand could be further complicated by a drop-off in federal funding.

Clinical laboratories prepare for coronavirus variants Adam Bonislawski, 360Dx NEW YORK – As new variants of SARS-CoV-2 continue to emerge, clinical labs are having to develop new and evolve existing approaches to test for the virus. While existing molecular tests appear to be capable of detecting the new UK and South Africa SARS-Cov-2 strains that have been the focus of much recent attention and concern, the appearance of these and other variants could require changes in labs' testing processes and the development of better tools for monitoring the presence of relevant variants in the pati...

How will labs use expanded molecular testing capacities post-COVID-19? Adam Bonislawski, GenomeWeb Print With COVID-19 vaccinations beginning this week in the US, the country is entering a new stage of the pandemic that could ultimately end in widespread suppression of the virus. The implications of this development for the lab industry are not entirely clear, but after almost a year spent building out molecular capacities to meet COVID-19 test demand, the question of what to do with that capacity in a post-COVID-19 environment looms on the horizon. According to data from revenue cycle mana...